Form 4: Rocket Pharmaceuticals Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
John Militello, Vice President of Finance, Treasurer, and Principal Accounting Officer of Rocket Pharmaceuticals, sold shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units (RSUs).
Summary
- On October 31, 2024, John Militello, an officer at Rocket Pharmaceuticals, sold 917 shares of common stock at a price of $16.625 per share.
- The sale was executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
- Following the transaction, Militello directly owns 50,534 shares of Rocket Pharmaceuticals common stock.
Sentiment
Score: 6
Explanation: The document reflects a routine transaction (selling shares to cover taxes on vested RSUs). It's neutral in sentiment as it doesn't inherently indicate positive or negative performance for the company.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and do not necessarily indicate a negative outlook on the company's future.
Stakeholder Impact
- The sale of shares by an officer could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect.
Key Dates
| Date | Description |
|---|---|
| 10/31/2024 | Date of the transaction (sale of shares) |
| 11/04/2024 | Date of the signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.